SecBot SecBot
COURT-RULING ·Filed Mar 31, 2026

BDX

BECTON DICKINSON & CO
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

No trading action warranted. The recusal denial is a non-event, the underlying trade secret case is a routine single-employee dispute with no material financial exposure to a $42B company. Monitor for any future summary judgment or trial ruling that could impose damages or expand liability, but no near-term catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$156.34
T+0 close · Apr 1, 2026 · via day close
Latest settled
−0.74%
T+60 · $155.19
Vs SPY
−13.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 1 $156.34entry
  2. T+1 · 8mo ago −1.17%α −1.26% · $154.51
  3. T+5 · 7mo ago −0.56%α −4.33% · $155.46
  4. T+20 · 7mo ago −4.67%α −14.35% · $149.04
  5. T+60 · 5mo ago −0.74%α −13.82% · $155.19
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Magistrate Judge Espinosa denied a pro se defendant's motion for recusal in BD's trade secret misappropriation lawsuit against a former employee. The ruling is a routine procedural denial with no material financial impact on BDX, the underlying litigation continues on its existing track, and the preliminary injunction barring disclosure of BD's confidential information remains in place.

Court Ruling Details

Ruling Date
Mar 31, 2026
Court
United States District Court, District of New Jersey
Court Level
District
Judge
André M. Espinosa
Case Type
ip trade secret
Ruling Type
procedural
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Becton Dickinson filed a trade secret misappropriation suit against former employee Marina Ngo Tang on Dec 27, 2024.
  • A preliminary injunction was already granted barring Tang from disclosing BD's confidential information, with a narrow exception for government/attorney communications.
  • Defendant's recusal motion based on claims of judicial bias and hostile treatment was denied for failing to meet the substantial burden under 28 U.S.C. § 144.
  • The ruling is a procedural discovery-stage decision with zero financial exposure to BDX.
  • BDX's market cap is $42.1 billion; the case involves a single former employee's download of documents, immaterial in size.

Financial Impact

Zero, no damages awarded or sought in this ruling. The underlying case seeks return of confidential documents and injunctive relief, not monetary damages.

Risk Factors

  • No material risk from this procedural ruling. If the underlying case proceeds to a final judgment with damages, those could be material but are not quantified in any available document.
  • Defendant may attempt to appeal the recusal denial, but such interlocutory appeals are rarely granted and would not affect the merits.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
43% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-sunsftyc-BDX

Track record

17 reports on BDX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $214.52 Now $216.47 +0.91% settles Nov 18
  2. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  3. Nov 5, 202611d ago 144 Neutral 2/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  5. Nov 5, 202611d ago Press Release Neutral 3/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  6. Nov 4, 202612d ago Press Release Neutral 2/10 Entry $209.19 to $214.52 Now $216.47 +3.48% ▲ +2.55% +3.46% vs SPY
  7. Oct 26, 202621d ago 144 Neutral 2/10 Entry $195.03 to $198.17 Now $216.47 +10.99% ▲ +1.61% +3.60% vs SPY
  8. Oct 6, 20265w ago Press Release Neutral 2/10 Entry $180.30 to $187.37 Now $216.47 +20.06% ▲ +3.92% +4.06% vs SPY
  9. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $182.09 to $190.74 Now $216.47 +18.88% ▲ +4.75% +5.94% vs SPY
  10. Jul 22, 202616w ago 8-K Neutral 2/10 Entry $153.16 to $168.40 Now $216.47 +41.34% ▲ +9.95% +12.35% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jul 2, 2026